Biofourmis procures $100m Series C

Biofourmis, a provider of digital therapeutics that powers personalized predictive care, has closed $100 million in Series C financing.

Biofourmis, a provider of digital therapeutics that powers personalized predictive care, has closed $100 million in Series C financing. SoftBank Vision Fund 2 led the round with participation from Openspace Ventures, MassMutual Ventures, Sequoia Capital and EDBI.

Source: Press Release